Putnam Investments | Press Release |

Putnam Investments to Launch Two Innovative Active ETFs

Firm to Offer First Actively Managed Business Development Company ETF Additionally Putnam to Offer New Biology Revolution ETF

Putnam Investments to Launch Two Innovative Active ETFs

BOSTON, September 28, 2022 – On Friday, September 30, Putnam Investments will begin to offer two new transparent, actively managed, equity exchange-traded funds (ETFs). The firm will be launching Putnam BDC Income ETF, concentrating in business development companies (BDCs), and Putnam BioRevolutionTM ETF, centered on companies operating at the intersection of technology and biology in the “biology revolution.”

One important milestone of the upcoming launch is that the Putnam BDC Income ETF will represent the first actively managed BDC ETF in the marketplace, investing in a host of BDC opportunities with an eye toward generating income for investors.

“Putnam is excited to bring these two dynamic new strategies to market as we seek to address the long-term investment needs of advisors and their clients,” said Robert L. Reynolds, President and Chief Executive Officer, Putnam Investments. “Our firm is focused on providing unique and differentiated offerings -- delivered through a variety of vehicles -- that tap Putnam’s deep investing expertise and exceptional research capabilities.”

The two transparent, active equity ETF strategies to be launched by Putnam on September 30 are:

Putnam BDC Income ETF (NYSE Arca: PBDC)

  • Invests in exchange traded BDCs based in the U.S. and registered with the SEC. BDCs generally invest in, lend capital to or provide services to privately held U.S. companies or thinly traded U.S. public companies
  • Putnam has managed a similar non-public BDC-focused strategy for nearly five years
  • Managed by Michael Petro
Putnam BioRevolutionTM ETF (NYSE Arca: SYNB)
  • Invests in companies that seek to capitalize on the convergence of technological developments in the life sciences sector, including technology-enabling companies, synthetic biology companies, and companies that operate in industries that are likely to benefit from the biology revolution
  • Managed by William Rives
“We have identified BDCs and advances in the biology sector as providing distinctive opportunities for investors in rapidly evolving sectors of the economy,” said Carlo Forcione, Head of Product and Strategy at Putnam Investments. “Our new ETFs represent innovative, early-to-market offerings that will align well with the portfolio construction needs of our clients and the broader marketplace.”

Active ETF Lineup at Putnam

The two new ETFs available later this week will join the firm’s four existing active ETFs, launched by Putnam in May 2021: Putnam Focused Large Cap Growth ETF (NYSE Arca: PGRO), Putnam Focused Large Cap Value ETF (NYSE Arca: PVAL), Putnam Sustainable Future ETF (NYSE Arca: PFUT), and Putnam Sustainable Leaders ETF (NYSE Arca: PLDR).

Putnam’s ETFs employ the firm’s established active investment approach, characterized by rigorous fundamental research and advanced risk management techniques in pursuit of alpha generation for investors. At the same time, they have attractive features that have made ETFs popular more generally, including intraday liquidity and enhanced tax efficiency.

About Putnam Investments

Founded in 1937, Putnam Investments is a global money management firm with over 80 years of investment experience. At the end of August 2022, Putnam had $169 billion in assets under management. Putnam has offices in Boston, London, Munich, Singapore, Sydney and Tokyo. For more information, visit putnam.com.